You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

pf-00299804

Showing 1 - 15 of 15
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Tumors Trial in Canada (PF-00299804)

Completed
Has Results
  • Head and Neck Neoplasms
  • PF-00299804
  • Vancouver, British Columbia, Canada
  • +9 more
Jan 20, 2021

Carcinoma, Non Small Cell Lung Trial in Seoul (PF-00299804)

Completed
Has Results
  • Carcinoma, Non Small Cell Lung
  • PF-00299804
  • Seoul, Korea, Republic of
  • +2 more
Sep 24, 2020

Carcinoma, Non Small Cell Lung Trial in United States (PF-00299804)

Completed
Has Results
  • Carcinoma, Non Small Cell Lung
  • PF-00299804
  • Duarte, California
  • +18 more
May 20, 2019

Lung Cancer Trial in Worldwide (PF-00299804, Placebo)

Completed
Has Results
  • Lung Cancer
  • PF-00299804
  • Placebo
  • Arcadia, California
  • +88 more
Apr 7, 2020

Tumors Trial in Netherlands, United States (PF-00299804)

Completed
  • Neoplasms
  • PF-00299804
  • Los Angeles, California
  • +8 more
Dec 19, 2018

Glioblastoma, GBM, Glioblastoma Multiforme Trial in Boston, Detroit, Cleveland (PF-00299804)

Completed
  • Glioblastoma
  • +2 more
  • PF-00299804
  • Boston, Massachusetts
  • +3 more
Aug 14, 2018

Advanced Malignant Solid Tumors Trial in Buffalo, San Antonio (PF-00299804)

Completed
Has Results
  • Advanced Malignant Solid Tumors
  • PF-00299804
  • Buffalo, New York
  • +1 more
Apr 21, 2017

Non Small Cell Lung Cancer Trial in Australia, United States (PF-02341066, PF-00299804)

Completed
Has Results
  • Non Small Cell Lung Cancer
  • Aurora, Colorado
  • +9 more
Oct 6, 2015

Head and Neck Squamous Cell Carcinoma Trial in Toronto (PF-00299804)

Completed
  • Head and Neck Squamous Cell Carcinoma
  • PF-00299804
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Jul 9, 2015

Oral Cavity Cancer Trial in Toronto (PF-00299804)

Completed
  • Oral Cavity Cancer
  • PF-00299804
  • Toronto, Ontario, Canada
    Princess Margaret Hospital
Jul 8, 2015

NSCLC Trial in Worldwide (Erlotinib, PF-00299804)

Completed
Has Results
  • Non-small Cell Lung Cancer
  • Muscle Shoals, Alabama
  • +58 more
Sep 22, 2015

Head Neck Cancer Squamous Cell Metastatic, Head Neck Cancer Squamous Cell Recurrent Trial in Daegu, Seoul (PF-00299804)

Completed
  • Head Neck Cancer Squamous Cell Metastatic
  • Head Neck Cancer Squamous Cell Recurrent
  • PF-00299804
  • Daegu, Korea, Republic of
  • +5 more
Sep 28, 2014

Carcinoma, Non-Small Cell, Tumor Metastasis Trial in France, Spain, United States (PF-00299804)

Completed
  • Carcinoma, Non-Small Cell
  • Neoplasm Metastasis
  • PF-00299804
  • Amherst, New York
  • +4 more
Oct 7, 2013

NSCLC (NSCLC) Trial in Birmingham, Los Angeles (PF-00299804)

Terminated
  • Non-Small Cell Lung Cancer (NSCLC)
  • PF-00299804
  • Birmingham, Alabama
  • +2 more
Jun 21, 2012

Tumors Trial in Sunto-gun (PF-00299804)

Completed
  • Neoplasms
  • PF-00299804
  • Sunto-gun, Shizuoka, Japan
    Pfizer Investigational Site
Jun 22, 2011